Supplementary material: Topical vs Systemic Corticosteroids for DRESS Syndrome: Real-World Outcomes from a Multi-Center Retrospective Cohort

Supplemental table 1: Culprit drug classes in patients with single-agent and multiple-agent DRESS, stratified by treatment group. Supplemental Table 2: Escalation to systemic corticosteroid by topical corticosteroid potency, dichotomized as very high and high potency (Class I–II) vs medium to very low potency (Class III+)